131350P.pdf   03/10/2014  Timothy Boehm  v.  Eli Lilly & Company
   U.S. Court of Appeals Case No:  13-1350
   U.S. District Court for the Eastern District of Arkansas - Little Rock   
   [PUBLISHED] [Loken, Author, with Colloton and Benton, Circuit Judges] 
   Civil case - Products liability. In action alleging defendant failed to 
   warn treating and prescribing physicians of the risk that long-term use of 
   the antipsychotic drug Zyprexa could lead patients to develop tardive 
   dyskinesia, the district court did not abuse its discretion by excluding 
   plaintiff's expert's testimony that 15% of users would develop the 
   condition as the testimony was not supported by sufficient scientific data 
   or sources; the district court did not err in granting defendant's motion 
   for summary judgment on plaintiff's failure-to-warn claim based on 
   Arkansas's learned intermediary doctrine; assuming Arkansas would 
   recognize an "over-promtion" exception to the learned intermediary 
   doctrine, there was no evidence that defendant over-promoted the drug, 
   thereby negating an otherwise adequate warning of risk.